Transcriptome Alterations in Liver Metastases of Colorectal Cancer After Acquired Resistance to Cetuximab
Authors:ZONGCHENG LI1,2,#, YULING CHEN3,#, WU REN1,4, SHUOFENG HU1, ZHAOLI TAN3, YAN WANG3, YAOWEN CHEN1,5, JIAN ZHANG1, JIAQI WU1, TINGTING LI6,7, JIANMING XU3 and XIAOMIN YING1
1 Center for Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing, P. R. China
2 State Key Laboratory of Proteomics, Translational Medicine Center of Stem Cells, 307-Ivy Translational Medicine Center, Laboratory of Oncology, Affiliated Hospital, Academy of Military Medical Sciences, Beijing, China
3 Department of GI Oncology, 307 Hospital of PLA, Academy of Military Medical Sciences, Beijing, P. R. China
4 Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P. R. China
5 Department of Obstetrics and Gynecology, Fuzhou General Hospital of Nanjing Military Command, Fuzhou, P. R. China
6 Department of Geriatric Gastroenterology, Chinese People's Liberation Army General Hospital, Beijing, P. R. China
7 State Key Laboratory of Kidney Diseases, Chinese People's Liberation Army General Hospital, Beijing, P. R. China
#These Authors contributed equally to this work.
Correspondence to: Xiaomin Ying, PhD, Center of Computational Biology, Beijing Institute of Basic Medical Sciences, Beijing 100850, P. R. China. Tel: +861068213039, e-mail: yingxmbio@foxmail.com; yingxm@bmi.ac.cn; Jianming Xu, MD, Department of GI Oncology, 307 Hospital of PLA, Academy of Military Medical Sciences, Beijing 100071, P. R. China. Tel: +861051128358, e-mail: jmxu2003@yahoo.com
Supplement
Supplementary Figure 1. Workflow of transcriptome analysis.
